Presence of antineutrophil cytoplasmic antibodies (ANCA) and anti Saccharomyces cerevisiae antibodies (ASCA) among patients with ulcerative colitis;Prevalencia de marcadores serológicos ANCA y ASCA en una población con colitis ulcerosa

Revista Medica de Chile

Volumn 134, Issue 8, 2006, Pages 960-964

  Vergara Albarracín, María Teresa ^a,c,d   Cofré L, Pamela ^a   Cifuentes A, Soledad ^b   Pulgar A, Ursula ^b   Puebla A, Claudio ^a   Velasco P, Susana ^a  

^a HOSPITAL NAVAL ALMIRANTE NEF   (Chile)

^b UNIVERSIDAD DE VALPARAÍSO   (Chile)

^c Centro Diagnóstico Digestivo CEDID   (Chile)

^d NONE   (United States)

Author keywords

Antibodies; Antineutrophil cytoplasmic; Colitis, ulcerative; Saccharomyces cerevisiae

Indexed keywords

EID: 33751275020     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Stewenius J, Adnerhill I, Ekelund G, Floren CH, Fork FT, Janzon L et al. Ulcerative colitis and indeterminate colitis in the city of Malmo, Sweden. A 25-year incidence study. Scand J Gastroenterol 1995; 30: 38-43.
2. Gisbert JP, Gomollón F, Maté J, Pajares JM. The role of anti-neutrophil cytoplasmic antibodies (ANCA) and anti-Saccharomyces cerevisiae antibodies (ASCA) in inflammatory bowel disease. Gastroenterol Hepatol 2003; 26: 312-24.
3. Saxon A, Shanahan F, Landers C, Ganz T, Targan S. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990; 86: 202-10.
4. Lombardi G, Annese V, Piepoli A, Bovio P, Latiano A, Napolitano G et al. Antineutrophil cytoplasmic antibodies in inflammatory bowel disease: clinical role and review of the literature. Dis Colon Rectum 2000; 43: 999-1007.
5. Duerr RH, Targan SR, Landers CJ, Sutherland LR, Shanahan F. Antineutrophil cytoplasmic antibodies in ulcerative colitis: comparison with other colitides/diarrheal illnesses. Gastroenterology 1991; 100: 1590-6.
6. Duerr RH, Targan SR, Landers CJ, Larusso NF, Lindsay KL, Wiesner RH et al. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1991; 100: 1385-91.
7. Seibold F, Weber P, Klein R, Berg PA, Wiedmann KH. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut 1992; 33: 657-62.
8. Broekroelofs J, Mulder AHL, Nelis GF, Westerveld BD, Cohen Tervaert JW, Kallenberg CGM. Antineutrophil cytoplasmic antibodies (ANCA) in sera from patients with inflammatory bowel disease (IBD). Dig Dis Sci 1994; 39: 545-9.
9. Vasiliauskas EA, Plevy SE, Landers CJ, Binder SW, Ferguson DM, Yang H et al. Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup. Gastroenterology 1996; 110: 1810-9.
10. Oudkerk Pool M, Ellerbroek PM, Ridwan BU, Goldschmeding R, Von Blomberg BME, Peña AS et al. Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment. Gut 1993; 34: 46-50.
11. Seibold F, Slametschka D, Gregor M, Weber P. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1994; 107: 532-6.
12. Klein R, Eisenburg J, Weber P, Seibold F, Berg PA. Significance and specificity of antibodies to neutrophils detected by western blotting for the serological diagnosis of primary sclerosing cholangitis. Hepatology 1991; 14: 1147-52.
13. Papo M, Quer JC, Pastor RM, García-Pardo G, Olona M, Prats E et al. Antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Med Clin (Barc) 1998; 110: 11-5.
14. Hoffman G, Specks U. Antineutrophil Cytoplasmic Antibodies. Arthritis & Rheumatism 1998;41:1521-37.
15. Rump JA, Scholmerich J, Gross V, Roth M, Helfesrieder R, Rautmann A et al. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. Immunobiology 1990; 181: 406-13.
16. Reumaux D, Sendid B, Poulain D, Duthilleul P, Dewit O, Colombel JF. Serological markers in inflammatory bowel diseases. Best Pract Res Clin Gastroenterol 2003; 17: 19-35.
17. Linskens R, Mallant-Hent RC, Groothuismink ZM, Bakker-Jonges LE, Van De Merwe JP, Hooijkaas H et al. Evaluation of serological markers to differentiate between ulcerative colitis and Crohn's disease: pANCA, ASCA and agglutinating antibodies to anaerobic coccoid rods. Eur J Gastroenterol Hepatol 2002; 14: 1013-8.
18. Quinton JF, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1998; 42: 788-91.
19. Peeters M, Joossens S, Vermeire S, Vlietinck R, Bossuyt X, Rutgeerts P. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol 2001; 96: 730-4.
20. Sandborn WJ, Landers CJ, Tremaine WJ, Targan SR. Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis: results of a pilot study. Mayo Clin Proc 1996; 71: 431-6.
21. Sobajima Ozaki S, Okazaki T, Osakada F, Sumita S, Mori K, Nakao K. Anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis: anticathepsin G and a novel antibody correlate with a refractory type. Antineutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis: anti-cathepsin G and a novel antibody correlate with a refractory type. Clin Exp Immunol 1996; 105: 120-4.
22. Brimnes J, Neilsen OH, Wiik A, Heegaard NH. Autoantibodies to molecular targets in neutrophils in patients with ulcerative colitis. Dig Dis Sci 1999; 44: 415-23.